HOME >> BIOLOGY >> NEWS
NIAMS funds the North American Spondylitis Consortium

The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) has awarded $4.5 million to establish the North American Spondylitis Consortium (NASC) to search for genes that determine susceptibility to ankylosing spondylitis (AS), a rare but painful inflammatory disease of the spine, primarily affecting men. The gene HLA-B27 is known to be linked to AS; however, researchers believe that there are additional genes associated with its pathogenesis.

The consortium, made up of researchers with a background in clinical and genetic research in AS, hopes to learn more about genes that play a role in the disease. They plan to collect medical information and genetic material (DNA) from 400 families nationwide in which two or more siblings have AS. The project will be headed by John D. Reveille, M.D., of the University of Texas-Houston Health Science Center, along with investigators at nine other research centers and staff from the Spondylitis Association of America.

"We are encouraged by the possibilities for development of new approaches for the diagnosis and treatment of ankylosing spondylitis as a result of this research project," says Stephen I. Katz, M.D., Ph.D., director of the NIAMS.

Ankylosing spondylitis, also known as arthritis of the spine, is a rheumatic disease that causes inflammation of the tendons and ligaments around the bones and joints in the spine. The result is pain and stiffness, especially in the lower back. While AS primarily affects the spine, it can also cause inflammation in the hips, shoulders and knees. AS usually begins in late adolescence or early adulthood. The disease is primarily diagnosed in men; however, recently, diagnosis of AS among women has increased.

Treatment for AS is designed to reduce inflammation in the joints and maintain flexibility. Therapy includes nonsteroidal anti-inflammatory drugs such as ibuprofen, disease-modifying drugs such as sulfasalazine and methotrexate, and to
'"/>

Contact: Kelli Carrington
carringk@mail.nih.gov
301-496-8190
NIH/National Institute of Arthritis and Musculoskeletal and Skin Diseases
27-Sep-1999


Page: 1 2 3

Related biology news :

1. NIAMS funds multicenter study of surgical vs. nonsurgical treatment of back pain
2. NIGMS funds Center for Quantitative Biology
3. $5 million grant funds partnership, studies of minority-based issues in reproductive health
4. NIH funds new Boston College-Boston University study of B-1a cell associated with leukemia
5. NSF funds summer research program abroad for undergraduates at UC San Diego
6. Research to create lung-cancer blood tests receives $3.4M in Pennsylvania tobacco settlement funds
7. The DFG funds a new research vessel
8. NIH funds Breast Cancer and the Environmental Research Center at Fox Chase Cancer Center
9. Grant funds research to develop tissue-engineered solutions for heart disease
10. Stuart research funds generating dividends for veterinary medicine
11. Grant funds research to develop microbicide barrier to HIV

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/23/2020)... ... 2020 , ... The field of quantitation of large molecules or proteins has ... area. However, the use of mass spectrometry in this field has gained a lot ... do you choose which approach to use (LBA or MS)?” In many cases, ...
(Date:6/19/2020)... ... June 18, 2020 , ... Join experts from Envigo ... in a live webinar on Wednesday, July 8, 2020 at 11am EDT ... we genetically engineer new models. However, while modifying the genome may be more straightforward, ...
(Date:6/5/2020)... ... June 04, 2020 , ... “Although we are disappointed ... well-being of our attendees, staff, and the public. We remain committed to creating ... ways to collaborate virtually,” said Julie Sutcliffe, President of WMIS. , ...
Breaking Biology News(10 mins):
(Date:6/2/2020)... ... June 01, 2020 , ... As part of its ongoing ... the world, enterprise security solutions provider bitsIO donated time to help two companies ... during self-quarantines and shelter-in-place orders, companies are increasingly concerned about the security of ...
(Date:5/28/2020)... Switzerland (PRWEB) , ... May 28, 2020 , ... ... biopharmaceutical R&D, today announced the release of Genedata Screener ® 17.0, the ... of screening data from all in-vitro screening assay technologies. Genedata will host a ...
(Date:5/21/2020)... ... May 21, 2020 , ... ... trials will cause long-term harm , Contrary to conventional wisdom that says the ... finds many companies will emerge from the pandemic commercially weaker, dealing with ...
(Date:5/21/2020)... Calif. (PRWEB) , ... May 20, 2020 , ... ... the addition of Simon Prakash, who will serve as the company’s executive vice ... at a time when Exo is disrupting the medical imaging space, bringing more ...
Breaking Biology Technology:
Cached News: